Document is current
Any future updates will be listed below
-
Authors
Brieghel, Christian https://orcid.org/0000-0002-1816-8106
Slørdahl, Tobias Schmidt https://orcid.org/0000-0001-7488-4863
Andersen, Morten Nørgaard
Szabo, Agoston Gyula https://orcid.org/0000-0001-9943-7007
Niemann, Carsten Utoft https://orcid.org/0000-0001-9880-5242
Thorsteinsdóttir, Sigrún
- License Information
-
More Information
Article History
Received: 10 January 2025
Revised: 17 March 2025
Accepted: 25 March 2025
First Online: 7 April 2025
Competing interests
: CB received travel grants from AbbVie outside this study. TSS has received honoraria from Takeda, Celgene, Amgen, Janssen, AbbVie, Pfizer; Consultancy for Bristol Myers Squibb, GSK, Pfizer, Menarini Group, and advisory board consultancy from Sanofi, Bristol Myers Squibb, Sanofi, Amgen, Celgene, GSK, and Janssen outside this study. CUN received research funding and/or consultancy fees from AstraZeneca, Janssen, AbbVie, Beigene, Genmab, CSL Behring, Octapharma, Takeda, Eli Lily, MSD, and Novo Nordisk Foundation. ST has received honoraria for scientific talks from AbbVie and Thermo Fisher Scientific. All other authors declare no competing interests.
